Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa C Rohan

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Plos One|May 6, 2015
A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)Ian Mcgowan, Ross D Cranston, Kathryn Duffill, et al.
AIDS Research and Human Retroviruses|August 13, 2021
A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study)Ian M McGowan, Sylvain Chawki, Craig W Hendrix, et al.
Plos One|July 31, 2018
Cryopreservation of human mucosal tissuesSean M Hughes, April L Ferre, Sarah E Yandura, et al.
The Journal of Infectious Diseases|November 29, 2023
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)Ethel D Weld, Ian McGowan, Peter Anton, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Plos One|May 6, 2015
A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)Ian Mcgowan, Ross D Cranston, Kathryn Duffill, et al.
AIDS Research and Human Retroviruses|August 13, 2021
A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study)Ian M McGowan, Sylvain Chawki, Craig W Hendrix, et al.
Plos One|July 31, 2018
Cryopreservation of human mucosal tissuesSean M Hughes, April L Ferre, Sarah E Yandura, et al.
The Journal of Infectious Diseases|November 29, 2023
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)Ethel D Weld, Ian McGowan, Peter Anton, et al.
Pageof 9